You are viewing an incomplete version of our website. Please click to reload the website as full version.

Ubiquitin-Conjugating Enzyme E2 Variant 1 (UBE2V1) (C-Term), (Isoform 3) antibody

Details for Product No. ABIN357577, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms CIR1, CROC-1, CROC1, UBE2V, UEV-1, UEV1, UEV1A, 0610011J09Rik, AI256840, D7Bwg1382e, CROC-1B
C-Term, Isoform 3
(29), (10), (7), (4), (2), (2), (2), (2), (1), (1)
(78), (32), (25)
(63), (12), (5)
(4), (4), (4), (3), (3), (3), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Enzyme Immunoassay (EIA), Western Blotting (WB)
(65), (36), (11), (7), (4), (4), (1), (1)
Pubmed 5 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 0.4 mL
Shipping to United States ( )
Availability Will be delivered in 6 to 8 Business Days
Immunogen This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human UBE2V1.
Isotype Ig
Specificity This antibody is specific to UBE2V1 (C-term, Isoform 3). Predicted to cross react with Mouse and Zebrafish (100 % Antigen Homology).
Purification Protein G Chromatography, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Alternative Name UBE2V1 / CROC1 (UBE2V1 Antibody Abstract)
Background The CROC1 isoforms, also known as UBE2V1, show sequence similarity to ubiquitin-conjugating enzymes (UBCs, or E2s) but lack the conserved cysteine residue critical to catalytic activity of E2s.1 Northern blot analysis detected approximately 2.1- and 2.5-kb CROC1 transcripts in all human tissues examined, with the highest levels in brain, skeletal muscle, and kidney. Partial human intestinal epithelial cell cDNAs have been isolated containing the 3-primecoding sequence and 3-prime untranslated region of UBE2V1, also called UEV1.2 UEV1 does not have ubiquitin-conjugating activity in vitro. UEV1 transcripts are downregulated upon differentiation of a colon carcinoma cell line.1 Constitutive expression of exogenous UEV1 protein in these colon carcinoma cells inhibits their capacity to differentiate upon confluence and induces changes in cell cycle behavior associated with inhibition of CDK1. A heterodimeric protein complex has been identified that links TRAF6 to IKK activation.3 Peptide mass fingerprinting analysis revealed that this complex is composed of the ubiquitin conjugating enzyme UBC13 and the UBC-like protein UBE2V1, also called UEV1A. TRAF6, a RING domain protein, functions together with UBC13/UEV1A to catalyze the synthesis of unique polyubiquitin chains linked through lysine-63 (K63) of ubiquitin. Blockade of this polyubiquitin chain synthesis, but not inhibition of the proteasome, prevents the activation of IKK by TRAF6. These results unveil a new regulatory function for ubiquitin, in which IKK is activated through the assembly of K63-linked polyubiquitin chains.Synonyms: CROC-1, P/OKcl.19, TRAF6-regulated IKK activator 1 beta Uev1A, UBE2V, UEV-1, UEV1, Ubiquitin-conjugating enzyme E2 variant 1
Molecular Weight 19307 Da
Gene ID 387522
NCBI Accession NP_001027459
UniProt Q13404
Pathways Fc-epsilon Receptor Signaling Pathway
Application Notes ELISA: 1/1,000. Western Blot: 1/100-1/500.
Restrictions For Research Use only
Format Liquid
Concentration 0.25 mg/mL
Buffer PBS with 0.09 % (W/V) Sodium Azide as preservative.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice Avoid repeated freezing and thawing.
Storage 4 °C/-20 °C
Storage Comment Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
Supplier Images
 image for anti-Ubiquitin-Conjugating Enzyme E2 Variant 1 (UBE2V1) (C-Term), (Isoform 3) antibody (ABIN357577) anti-Ubiquitin-Conjugating Enzyme E2 Variant 1 (UBE2V1) (C-Term), (Isoform 3) antibody
Background publications Thomson, Lozano, Loukili et al.: "Fusion of the human gene for the polyubiquitination coeffector UEV1 with Kua, a newly identified gene." in: Genome research, Vol. 10, Issue 11, pp. 1743-56, 2000 (PubMed).

Long: "A new function evolved from gene fusion." in: Genome research, Vol. 10, Issue 11, pp. 1655-7, 2000 (PubMed).

Deng, Wang, Spencer et al.: "Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain." in: Cell, Vol. 103, Issue 2, pp. 351-61, 2000 (PubMed).

Hofmann, Pickart: "Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair." in: Cell, Vol. 96, Issue 5, pp. 645-53, 1999 (PubMed).

Ma, Broomfield, Lavery et al.: "Up-regulation of CIR1/CROC1 expression upon cell immortalization and in tumor-derived human cell lines." in: Oncogene, Vol. 17, Issue 10, pp. 1321-6, 1998 (PubMed).

Catalog No. ABIN357577
Plus shipping costs $45.00

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)